CRISPR Therapeutics (CRSP) PT Lowered to $98 at Jefferies
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $54.36 --0%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
Jefferies analyst Maury Raycroft lowered the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $98.00 (from $100.00) while maintaining a Buy rating.
You May Also Be Interested In
- Outdoor Holding (POWW) PT Raised to $2.75 at Roth/MKM, reiterates Top Pick
- Klarna (KLAR) PT Raised to $19 at BMO Capital
- GeneDx (WGS) PT Raised to $63 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
